Effects of a Self-Guided Transdiagnostic Smartphone App on Patient Empowerment and Mental Health: Randomized Controlled Trial.
help-seeking attitude
internet-based interventions
mental health literacy
mental health–related self-management skills
patient empowerment
self-guided
transdiagnostic mental health app
unguided
Journal
JMIR mental health
ISSN: 2368-7959
Titre abrégé: JMIR Ment Health
Pays: Canada
ID NLM: 101658926
Informations de publication
Date de publication:
06 Nov 2023
06 Nov 2023
Historique:
received:
15
12
2022
accepted:
04
08
2023
revised:
01
08
2023
medline:
6
11
2023
pubmed:
6
11
2023
entrez:
6
11
2023
Statut:
epublish
Résumé
Mental disorders impact both individuals and health systems. Symptoms and syndromes often remain undetected and untreated, resulting in chronification. Besides limited health care resources, within-person barriers such as the lack of trust in professionals, the fear of stigmatization, or the desire to cope with problems without professional help contribute to the treatment gap. Self-guided mental health apps may support treatment seeking by reducing within-person barriers and facilitating mental health literacy. Digital mental health interventions may also improve mental health related self-management skills and contribute to symptom reduction and the improvement of quality of life. This study aims to investigate the effects of a self-guided transdiagnostic app for mental health on help seeking, reduced stigma, mental health literacy, self-management skills, mental health symptoms, and quality of life using a randomized controlled design. Overall, 1045 participants (recruited via open, blinded, and web-based recruitment) with mild to moderate depression or anxiety-, sleep-, eating-, or somatization-related psychopathology were randomized to receive either access to a self-guided transdiagnostic mental health app (MindDoc) in addition to care as usual or care as usual only. The core features of the app were regular self-monitoring, automated feedback, and psychological courses and exercises. The coprimary outcomes were mental health literacy, mental health-related patient empowerment and self-management skills (MHPSS), attitudes toward help seeking, and actual mental health service use. The secondary outcomes were psychopathological symptom burden and quality of life. Data were collected at baseline and 8 weeks and 6 months after randomization. Treatment effects were investigated using analyses of covariance, including baseline variables as predictors and applying multiple imputation. We found small but robust between-group effects for MHPSS (Cohen d=0.29), symptoms burden (Cohen d=0.28), and quality of life (Cohen d=0.19) 8 weeks after randomization. The effects on MHPSS were maintained at follow-up. Follow-up assessments also showed robust effects on mental health literacy and preliminary evidence for the improvement of help seeking. Predictors of attrition were lower age and higher personality dysfunction. Among the non-attritors, predictors for deterioration were less outpatient treatment and higher initial symptom severity. A self-guided transdiagnostic mental health app can contribute to lasting improvements in patient empowerment. Symptoms of common mental disorders and quality of life improved faster in the intervention group than in the control group. Therefore, such interventions may support individuals with symptoms of 1 or more internalizing disorders, develop health-centered coping skills, prevent chronification, and accelerate symptom improvement. Although the effects for individual users are small and predictors of attrition and deterioration need to be investigated further, the potential public health impact of a self-guided intervention can be large, given its high scalability. German Clinical Trials Register DRKS00022531; https://drks.de/search/de/trial/DRKS00022531.
Sections du résumé
BACKGROUND
BACKGROUND
Mental disorders impact both individuals and health systems. Symptoms and syndromes often remain undetected and untreated, resulting in chronification. Besides limited health care resources, within-person barriers such as the lack of trust in professionals, the fear of stigmatization, or the desire to cope with problems without professional help contribute to the treatment gap. Self-guided mental health apps may support treatment seeking by reducing within-person barriers and facilitating mental health literacy. Digital mental health interventions may also improve mental health related self-management skills and contribute to symptom reduction and the improvement of quality of life.
OBJECTIVE
OBJECTIVE
This study aims to investigate the effects of a self-guided transdiagnostic app for mental health on help seeking, reduced stigma, mental health literacy, self-management skills, mental health symptoms, and quality of life using a randomized controlled design.
METHODS
METHODS
Overall, 1045 participants (recruited via open, blinded, and web-based recruitment) with mild to moderate depression or anxiety-, sleep-, eating-, or somatization-related psychopathology were randomized to receive either access to a self-guided transdiagnostic mental health app (MindDoc) in addition to care as usual or care as usual only. The core features of the app were regular self-monitoring, automated feedback, and psychological courses and exercises. The coprimary outcomes were mental health literacy, mental health-related patient empowerment and self-management skills (MHPSS), attitudes toward help seeking, and actual mental health service use. The secondary outcomes were psychopathological symptom burden and quality of life. Data were collected at baseline and 8 weeks and 6 months after randomization. Treatment effects were investigated using analyses of covariance, including baseline variables as predictors and applying multiple imputation.
RESULTS
RESULTS
We found small but robust between-group effects for MHPSS (Cohen d=0.29), symptoms burden (Cohen d=0.28), and quality of life (Cohen d=0.19) 8 weeks after randomization. The effects on MHPSS were maintained at follow-up. Follow-up assessments also showed robust effects on mental health literacy and preliminary evidence for the improvement of help seeking. Predictors of attrition were lower age and higher personality dysfunction. Among the non-attritors, predictors for deterioration were less outpatient treatment and higher initial symptom severity.
CONCLUSIONS
CONCLUSIONS
A self-guided transdiagnostic mental health app can contribute to lasting improvements in patient empowerment. Symptoms of common mental disorders and quality of life improved faster in the intervention group than in the control group. Therefore, such interventions may support individuals with symptoms of 1 or more internalizing disorders, develop health-centered coping skills, prevent chronification, and accelerate symptom improvement. Although the effects for individual users are small and predictors of attrition and deterioration need to be investigated further, the potential public health impact of a self-guided intervention can be large, given its high scalability.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trials Register DRKS00022531; https://drks.de/search/de/trial/DRKS00022531.
Identifiants
pubmed: 37930749
pii: v10i1e45068
doi: 10.2196/45068
pmc: PMC10660244
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e45068Informations de copyright
©André Kerber, Ina Beintner, Sebastian Burchert, Christine Knaevelsrud. Originally published in JMIR Mental Health (https://mental.jmir.org), 06.11.2023.
Références
Annu Rev Clin Psychol. 2021 May 7;17:83-108
pubmed: 33577350
Lancet. 2018 Feb 17;391(10121):679-686
pubmed: 29224931
Psychosom Med. 2016 Jul-Aug;78(6):728-39
pubmed: 27187850
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(1. Vyp. 2):55-61
pubmed: 31006793
BMC Psychiatry. 2010 Dec 30;10:113
pubmed: 21192795
JAMA Psychiatry. 2020 Sep 1;77(9):915-924
pubmed: 32401286
J Med Internet Res. 2020 Jun 9;22(6):e15001
pubmed: 32515740
Assessment. 2022 Apr;29(3):467-487
pubmed: 33371717
J Affect Disord. 2020 Mar 15;265:287-304
pubmed: 32090753
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Affect Disord. 2009 May;115(1-2):196-200
pubmed: 18799220
Z Psychosom Med Psychother. 2015;61(3):262-74
pubmed: 26388057
JAMA Netw Open. 2020 Apr 1;3(4):e203221
pubmed: 32315069
Cogn Behav Ther. 2016 Apr;45(3):236-57
pubmed: 27046641
PLoS Med. 2021 Jun 10;18(6):e1003664
pubmed: 34111122
Front Psychiatry. 2021 Jun 14;12:648367
pubmed: 34194347
J Behav Ther Exp Psychiatry. 2006 Sep;37(3):213-38
pubmed: 16126161
Cogn Behav Ther. 2018 Jan;47(1):43-61
pubmed: 28724338
BMC Psychiatry. 2019 Jan 28;19(1):46
pubmed: 30691421
Br J Psychiatry. 2004 Oct;185:342-9
pubmed: 15458995
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 May;56(5-6):740-8
pubmed: 23703493
BMC Psychiatry. 2006 Apr 05;6:13
pubmed: 16595018
Glob Qual Nurs Res. 2015 Sep 21;2:2333393615606092
pubmed: 28462317
Arch Gen Psychiatry. 2011 Jan;68(1):90-100
pubmed: 21199968
Patient Educ Couns. 2013 Jun;91(3):271-9
pubmed: 23414831
J Affect Disord. 2016 Jul 15;199:30-41
pubmed: 27060430
BMJ Open. 2021 Jul 15;11(7):e049688
pubmed: 34266843
Scand J Public Health Suppl. 2005 Oct;66:29-35
pubmed: 16214720
Health Expect. 2015 Oct;18(5):1339-48
pubmed: 23910797
J Psychosom Res. 2017 Oct;101:44-50
pubmed: 28867423
Psychol Med. 2023 Jan;53(2):567-579
pubmed: 34047264
Psychol Med. 2018 Nov;48(15):2456-2466
pubmed: 29540243
Curr Opin Psychiatry. 2022 Mar 1;35(2):130-135
pubmed: 34966117
J Affect Disord. 2020 Mar 15;265:395-401
pubmed: 32090765
J Clin Epidemiol. 2019 Jun;110:63-73
pubmed: 30878639
Dialogues Clin Neurosci. 2016 Jun;18(2):203-12
pubmed: 27489460
Cogn Behav Pract. 2014 May;21(2):111-123
pubmed: 25620867
Psychiatr Serv. 2010 Nov;61(11):1099-105
pubmed: 21041348
J Affect Disord. 2014 Oct;168:65-71
pubmed: 25038293
Psychol Med. 2014 Apr;44(6):1303-17
pubmed: 23931656
JAMA. 2013 Nov 6;310(17):1818-28
pubmed: 24193079
J Consult Clin Psychol. 2020 Jan;88(1):1-13
pubmed: 31697093
Community Ment Health J. 2010 Apr;46(2):130-8
pubmed: 20033488
Am J Manag Care. 2007 Nov;13(4 Suppl):S92-7
pubmed: 18041868
Psychol Med. 2011 Aug;41(8):1751-61
pubmed: 21134315
JAMA Psychiatry. 2017 Sep 1;74(9):875-884
pubmed: 28768327
Annu Rev Public Health. 2013;34:119-38
pubmed: 23514317
PLoS One. 2020 Jul 6;15(7):e0234349
pubmed: 32628678
Psychol Bull. 2021 Aug;147(8):749-786
pubmed: 34898233
Patient. 2014;7(1):85-96
pubmed: 24271592
Cogn Behav Ther. 2017 Jan;46(1):1-28
pubmed: 27712544
JAMA Psychiatry. 2022 Feb 1;79(2):101-108
pubmed: 34878526
J Affect Disord. 2018 Mar 1;228:160-165
pubmed: 29248822
J Ment Health. 2012 Apr;21(2):114-26
pubmed: 22142324
Am J Public Health. 2014 Mar;104(3):488-97
pubmed: 24432951
Psychosom Med. 2002 Mar-Apr;64(2):258-66
pubmed: 11914441
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
World Psychiatry. 2019 Oct;18(3):325-336
pubmed: 31496095
J Med Internet Res. 2020 Jul 14;22(7):e15361
pubmed: 32673233
BMJ Open. 2019 Feb 22;8(11):e026137
pubmed: 30798295
JAMA Psychiatry. 2021 Apr 1;78(4):361-371
pubmed: 33471111
J Affect Disord. 2019 Mar 1;246:695-705
pubmed: 30611913
Nervenarzt. 2014 Jan;85(1):77-87
pubmed: 24441882
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
Psychol Med. 2015 Oct;45(13):2717-26
pubmed: 25881626
BJPsych Open. 2016 Feb 1;2(1):50-58
pubmed: 27703754
Clin Psychol Rev. 2022 Aug;96:102179
pubmed: 35763975
Am J Public Health. 1999 Sep;89(9):1322-7
pubmed: 10474547
Psychol Med. 2016 Oct;46(13):2679-93
pubmed: 27649340
Curr Psychiatry Rep. 2019 Aug 13;21(9):92
pubmed: 31410586
Aust N Z J Psychiatry. 2005 Mar;39(3):187-93
pubmed: 15701069
PLoS One. 2013 Jul 03;8(7):e62873
pubmed: 23843932
Psychol Med. 2018 Oct;48(13):2140-2152
pubmed: 29361995
Int J Health Serv. 1994;24(2):201-29
pubmed: 8034390
Psychopathology. 2020;53(3-4):179-188
pubmed: 32369820
J Med Internet Res. 2012 Jun 27;14(3):e68
pubmed: 22738715
Dtsch Arztebl Int. 2013 Nov 22;110(47):799-808
pubmed: 24314623
J Affect Disord. 2019 Feb 15;245:728-743
pubmed: 30447572
Br J Psychiatry. 2019 May;214(5):260-268
pubmed: 30898177
Health Qual Life Outcomes. 2013 Apr 22;11:65
pubmed: 23601161
J Clin Psychiatry. 2002;63 Suppl 8:24-34
pubmed: 12044105
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Int J Environ Res Public Health. 2018 Jun 23;15(7):
pubmed: 29937509
Focus (Am Psychiatr Publ). 2018 Oct;16(4):420-429
pubmed: 32021580
Clin Psychol Rev. 2021 Feb;83:101953
pubmed: 33422841
Clin Psychol Rev. 2015 Aug;40:91-110
pubmed: 26094079
Behav Res Ther. 2013 Feb;51(2):57-62
pubmed: 23262114
Psychother Psychosom. 2021;90(4):255-268
pubmed: 33321501